There is an increasing body of evidence suggesting that altered vascular permeability may
be an important component of the pathogenesis of acute mountain sickness (AMS). Vascular …

Study objectives To investigate the hypothesis that an increase in circulating vascular
endothelial growth factor (VEGF) occurs in mountaineers at high altitude, particularly in …

Study Objective: Despite causing significant morbidity throughout the mountainous regions
of the world, the pathophysiology of acute mountain sickness (AMS) remains poorly …

Vascular endothelial growth factor (VEGF) is an endothelial cell mitogen and permeability
factor that is inducible by hypoxia. Its contribution to high-altitude illness in man is unknown …

Abstract Schommer, Kai, Neele Wiesegart, Christoph Dehnert, Heimo Mairbäurl, and Peter
Bärtsch. No correlation between plasma levels of vascular endothelial growth factor or its …

Vascular endothelial growth factor (VEGF) is a hypoxia-induced protein that produces
vascular permeability, and limited evidence suggests a possible role for VEGF in the …

Background: Acute mountain sickness (AMS) is the most common disease caused by
hypobaric hypoxia (HH) in high-altitude (HA) associated with high mortality when …

Objective To determine if serum vascular endothelial growth factor (VEGF) and ultrasonic
monitoring of vascular dynamics with dynamic vascular analysis at sea level and high …

To examine the role of VEGF in the pathogenesis of high-altitude pulmonary edema (HAPE),
we measured the concentrations of VEGF in venous serum and bronchoalveolar lavage fluid …

Study objectives Mechanical or inflammatory injury to pulmonary endothelial cells may
cause impaired pulmonary gas exchange in acute mountain sickness (AMS) and …